QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 专题：复旦大学上海医学院    第一署名单位    第一作者单位    通讯作者单位     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Continuous positive airway pressure (CPAP) vs noninvasive positive pressure ventilation (NIPPV) vs noninvasive high frequency oscillation ventilation (NHFOV) as post-extubation support in preterm neonates: protocol for an assessor-blinded, multicenter, randomized controlled trial 期刊论文 BMC PEDIATRICS, 2019, 卷号: 19 作者:  Shi, Yuan;  De Luca, Daniele;  Yuan, Shi;  Wang, Jianhui;  Long, Chen 收藏  |  浏览/下载：118/0  |  提交时间：2019/12/05 Neonate  Noninvasive respiratory ventilation  Non invasive high frequency oscillatory ventilation   Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study 期刊论文 TARGETED ONCOLOGY, 2019, 卷号: 14, 期号: 2 作者:  Hong, Xiaonan;  Song, Yuqin;  Huang, Huiqiang;  Bai, Bing;  Zhang, Huilai 收藏  |  浏览/下载：23/0  |  提交时间：2019/12/05 Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for persistent/recurrent and metastatic differentiated thyroid cancer 2018 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2019, 卷号: 31, 期号: 1 作者:  Lin, Yansong;  Huang, Huiqiang;  Guo, Ye;  Chen, Libo;  Bao, Jiandong 收藏  |  浏览/下载：127/0  |  提交时间：2019/12/05 Association between bortezomib dose intensity and overall survival in mantle cell lymphoma patients on frontline VR-CAP in the phase 3 LYM-3002 study(*) 期刊论文 LEUKEMIA & LYMPHOMA, 2019, 卷号: 60, 期号: 1 作者:  Robak, Tadeusz;  Huang, Huiqiang;  Jin, Jie;  Zhu, Jun;  Liu, Ting 收藏  |  浏览/下载：24/0  |  提交时间：2019/12/05 Mantle cell lymphoma  R-CHOP  VR-CAP  bortezomib  LYM-3002  dose intensity   Bortezomib-based therapy for transplant-ineligible East Asian patients with newly diagnosed mantle-cell lymphoma 期刊论文 ONCOTARGETS AND THERAPY, 2018, 卷号: 11 作者:  Jin, Jie;  Okamoto, Rumiko;  Yoon, Sung-Soo;  Shih, Lee-Yung;  Zhu, Jun 收藏  |  浏览/下载：3/0  |  提交时间：2019/12/05 mantle-cell lymphoma  bortezomib  VR-CAP  R-CHOP   Chidamide in relapsed or refractory peripheral T cell lymphoma: a multicenter real-world study in China 期刊论文 JOURNAL OF HEMATOLOGY & ONCOLOGY, 2017, 卷号: 10 作者:  Liu, Peng;  Shi, Yuankai;  Jia, Bo;  Xu, Wei;  Li, Wenyu 收藏  |  浏览/下载：1/0  |  提交时间：2019/12/05 Chidamide  Peripheral T cell lymphoma  Treatment  Chemotherapy   Phase II Study of Chidamide, a New Subtype-Selective Oral Histone Deacetylase Inhibitor, in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma 会议论文 作者:  Shi, Yuankai;  Dong, Mei;  Zhu, Jun;  Zhou, Daobin;  Huang, Huiqiang 收藏  |  浏览/下载：11/0  |  提交时间：2019/12/13 Bortezomib-Based Therapy for Newly Diagnosed Mantle-Cell Lymphoma 期刊论文 NEW ENGLAND JOURNAL OF MEDICINE, 2015, 卷号: 372, 期号: 10 作者:  Robak, Tadeusz;  Huang, Huiqiang;  Jin, Jie;  Zhu, Jun;  Liu, Ting 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19 Bortezomib (Btz) Dose Intensity Is the Strongest Predictor for Overall Survival (OS) in Mantle Cell Lymphoma (MCL) Patients (Pts) Not Considered for Transplantation, Receiving Frontline Btz Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (VR-CAP) Therapy in the Phase 3 LYM-3002 Study 会议论文 作者:  Robak, Tadeusz;  Huang, Huiqiang;  Jin, Jie;  Zhu, Jun;  Liu, Ting 收藏  |  浏览/下载：9/0  |  提交时间：2019/12/19